http://www.legislation.gov.uk/eudr/1964/432/annex/B/division/2Council Directive of 26 June 1964 on animal health problems affecting intra-Community trade in bovine animals and swine (64/432/EEC)Council Directive of 26 June 1964 on animal health problems affecting intra-Community trade in bovine animals and swine (64/432/EEC)2020-12-12King's Printer of Acts of Parliamenthttps://webarchive.nationalarchives.gov.uk/eu-exit/https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:01964L0432-20150527texttext/xmlen2015-05-27 ANNEX B <Substitution ChangeId="O001001M002" CommentaryRef="c000001"> <Substitution ChangeId="O008001M001" CommentaryRef="c000021">TUBERCULOSIS</Substitution> </Substitution> 2. <Substitution ChangeId="O001001M002" CommentaryRef="c000001"> <Substitution ChangeId="O008001M001" CommentaryRef="c000021">THE TUBERCULIN SKIN TEST</Substitution> </Substitution>

Tuberculin PPD (Purified Protein Derivatives) that fulfil the standards laid down in paragraph 2.1 shall be used for carrying out official tuberculin skin test following the procedures referred to in paragraph 2.2.

2.1. <Substitution ChangeId="O001001M002" CommentaryRef="c000001"> <Substitution ChangeId="O008001M001" CommentaryRef="c000021">Standards for tuberculin (bovine and avian)</Substitution> </Substitution> 2.1.1. <Substitution ChangeId="O001001M002" CommentaryRef="c000001"> <Substitution ChangeId="O008001M001" CommentaryRef="c000021">Definition</Substitution> </Substitution>

Tuberculin purified protein derivative (tuberculin PPD, bovine or avian) is a preparation obtained from the heat-treated products of growth and lysis of Mycobacterium bovis or Mycobacterium avium (as appropiate) capable of revealing a delayed hypersensitivity in an animal sensitised to microorganisms of the same species.

2.1.2. <Substitution ChangeId="O001001M002" CommentaryRef="c000001"> <Substitution ChangeId="O008001M001" CommentaryRef="c000021">Production</Substitution> </Substitution>

It is obtained from the water-soluble fractions prepared by heating in free-flowing steam and subsequently filtering cultures of M. bovis or M. avium (as appropiate) grown in a liquid synthetic medium. The active fraction of the filtrate, consisting mainly of protein, is isolated by precipitation, washed and re-dissolved. An antimicrobial preservative that does not give rise to false positive reactions, such as phenol, may be added. The final sterile preparation, free from mycobacteria, is distributed aseptically into sterile tamper-proof glass containers which are then closed so as to prevent contamination. The preparation may be freeze-dried.

2.1.3. <Substitution ChangeId="O001001M002" CommentaryRef="c000001"> <Substitution ChangeId="O008001M001" CommentaryRef="c000021">Identification of the product</Substitution> </Substitution>

Inject a range of graded doses intradermally at different sites into suitably sensitised albino guinea-pigs, each weighing not less than 250 g. After 24 h to 28 h, reactions appear in the form of oedematous swellings with erythema with or without necrosis at the points of injection. The size and severity of the reactions vary according to the dose. Unsensitised guinea-pigs show no reactions to similar injections.

2.1.4. <Substitution ChangeId="O001001M002" CommentaryRef="c000001"> <Substitution ChangeId="O008001M001" CommentaryRef="c000021">Tests</Substitution> </Substitution> 2.1.4.1.

pH: The pH is 6.5 to 7.5.

2.1.4.2.

Phenol: If the preparation to be examined contains phenol, its concentration is not more than 5 g/l.

2.1.4.3.

Sensitising effect: Use a group of three guinea-pigs that have not been treated with any material which will interfere with the test. On 3 occasions at intervals of five days inject intradermally into each guinea-pig a dose of the preparation to be examined equivalent to 500 IU in 0,1 ml. 15 to 21 days after the third injection inject the same dose (500 IU) intradermally into these animals and into a control group of three guinea-pigs of the same mass and which have not previously received injections of tuberculin. 24 to 28 hours after the last injections, the reactions of the two groups are not significantly different.

2.1.4.4.

Toxicity: Use two guinea-pigs, each weighing not less than 250 g and which have not previously been treated with any material which will interfere with the test. Inject subcutaneously into each guinea-pig 0,5 ml of the preparation to be examined. Observe the animals for seven days. No abnormal effects occur during the observation period.

2.1.4.5.

Sterility: It complies with the test for sterility prescribed in the monograph on Vaccines for veterinary use 4th Edition 2002 of the European Pharmacopoeia.

2.1.5. <Substitution ChangeId="O001001M002" CommentaryRef="c000001"> <Substitution ChangeId="O008001M001" CommentaryRef="c000021">Potency</Substitution> </Substitution>

The potency of tuberculin purified protein derivative (bovine and avian) is determined by comparing the reactions produced in sensitised guinea-pigs by the intradermal injection of a series of dilutions of the preparation to be examined with those produced by known concentrations of a reference preparation of tuberculin (bovine or avian, as appropiate) purified protein derivative calibrated in International Units.

To test the potency, sensitise not fewer than nine albino guinea-pigs, each weighing 400 g to 600 g, by the deep intramuscular injection of 0,0001 mg of wet mass of living M. bovis of strain AN5 suspended in 0.5 ml of a 9 g/l solution of sodium chloride R for bovine tuberculin, or a suitable dose of inactivated or live M. avium for avian tuberculin. Not less than four weeks after the sensitisation of the guinea-pigs, shave their flanks to provide space for not more than four injection sites on each side. Prepare dilutions of the preparation to be examined and of the reference preparation using isotonic phosphate-buffered saline (pH 6,5-7,5) containing 0,005 g/l of polysorbate 80 R. Use not fewer than three doses of the reference preparation and not fewer than three doses of the preparation to be examined. Choose the doses such that the lesions produced have a diameter of not less than 8 mm and not more than 25 mm. Allocate the dilutions randomly to the sites using a Latin square design. Inject each dose intradermally in a constant volume of 0,1 ml or 0,2 ml. Measure the diameters of the lesions after 24 to 28 hours and calculate the result of the test using the usual statistical methods and assuming that the diameters of the lesions are directly proportional to the logarithm of the concentration of the tuberculins.

The test is not valid unless the fiducial limits of error (P = 0,95) are not less than 50 % and not more then 200 % of the estimated potency. The estimated potency is not less than 66 % and not more than 150 % of the stated potency for bovine tuberculin. The estimated potency is not less than 75 % and not more than 133 % of the stated potency for avian tuberculin. The stated potency is not less than 20 000 IU/ml for both tuberculins (bovine and avian).

2.1.6. <Substitution ChangeId="O001001M002" CommentaryRef="c000001"> <Substitution ChangeId="O008001M001" CommentaryRef="c000021">Storage</Substitution> </Substitution>

Store protected from light, at a temperature of 5 ± 3 o C.

2.1.7. <Substitution ChangeId="O001001M002" CommentaryRef="c000001"> <Substitution ChangeId="O008001M001" CommentaryRef="c000021">Labelling</Substitution> </Substitution>

The label states:

the potency in International Units per millilitre, the name and quantity of any added substance, for freeze-dried preparations: -the name and volume of the reconstituting liquid to be added, -that the product should be used immediately after reconstitution.

2.2. <Substitution ChangeId="O001001M002" CommentaryRef="c000001"> <Substitution ChangeId="O008001M001" CommentaryRef="c000021">Test procedures</Substitution> </Substitution> 2.2.1. <Substitution ChangeId="O001001M002" CommentaryRef="c000001"> <Substitution ChangeId="O008001M001" CommentaryRef="c000021">The following shall be recognised as official intradermal tuberculin tests:</Substitution> </Substitution>

the single intradermal test: this test requires a single injection of bovine tuberculin, the intradermal comparative test: this test requires one injection of bovine tuberculin and one injection of avian tuberculin given simultaneously.

2.2.2. <Substitution ChangeId="O001001M002" CommentaryRef="c000001"> <Substitution ChangeId="O008001M001" CommentaryRef="c000021">The dose of tuberculin injected shall be:</Substitution> </Substitution>

not less than 2 000 IU of bovine tuberculin, not less than 2 000 IU of avian tuberculin.

2.2.3.

The volume of each injection dose shall not exceed 0,2 ml.

2.2.4.

Tuberculin tests shall be carried out by injecting tuberculin(s) into the skin of the neck. The injection sites shall be situated at the border of the anterior and middle thirds of the neck. When both avian and bovine tuberculins are injected in the same animal, the site for injection of avian tuberculins shall be about 10 cm from the crest of the neck and the site for the injection of bovine tuberculin about 12,5 cm lower on a line roughly parallel with the line of the shoulder or on different sides of the neck; in young animals in which there is not room to separate the sites sufficiently on one side of the neck, one injection shall be made on each side of the neck at identical sites in the centre of the middle third of the neck.

2.2.5.

The technique of tuberculin testing and interpretation of reactions shall be as follows:

2.2.5.1. <Expanded> <Substitution ChangeId="O001001M002" CommentaryRef="c000001"> <Substitution ChangeId="O008001M001" CommentaryRef="c000021">Technique:</Substitution> </Substitution> </Expanded>

Injection sites shall be clipped and cleansed. A fold of skin within each clipped area shall be taken between the forefinger and thumb and measured with callipers and recorded. The dose of tuberculin shall then be injected by a method that ensures that the tuberculin is delivered intradermically. A short sterile needle, bevel edge outwards, with graduated syringe charged with tuberculin, inserted obliquely into the deeper layers of the skin may be used. A correct injection shall be confirmed by palpating a small pea-like swelling at each site of injection. The skin-fold thickness of each injection site shall be remeasured 72 hours (± 4 hours) after injection and recorded.

2.2.5.2. <Expanded> <Substitution ChangeId="O001001M002" CommentaryRef="c000001"> <Substitution ChangeId="O008001M001" CommentaryRef="c000021">Interpretation of reactions</Substitution> </Substitution> </Expanded>

The interpretation of reactions shall be based on clinical observations and the recorded increase(s) in skin-fold thickness at the sites of injection 72 hours after injection of tuberculin(s).

Negative reaction: if only limited swelling is observed, with an increase of not more than 2 mm in the thickness of the fold of skin without clinical signs such as diffuse or extensive oedema, exudation, necrosis, pain or inflammation of the lymphatic ducts in that region or of the lymph nodes. Inconclusive reaction: if no clinical signs such as mentioned in a) are observed and if the increase in skin-fold thickness is more than 2 mm and less than 4 mm. Positive reaction: if clinical signs such as mentioned in a) are observed or there is an increase of 4 mm or more in the thickness of the fold of skin at the injection site.

2.2.5.3.

The interpretation of official intradermal tuberculin tests shall be as follows:

2.2.5.3.1. <Substitution ChangeId="O001001M002" CommentaryRef="c000001"> <Substitution ChangeId="O008001M001" CommentaryRef="c000021">Single intradermal test:</Substitution> </Substitution>

positive: a positive bovine reaction as defined in paragraph 2.2.5.2(c); inconclusive: an inconclusive reaction as defined in paragraph 2.2.5.2(b); negative: a negative bovine reaction as defined in paragraph 2.2.5.2(a).

Animals inconclusive to the single intradermal test shall be subjected to another test after a minimum of 42 days.

Animals which are not negative to this second test shall be deemed to be positive to the test.

Animals positive to the single intradermal test may be subjected to an intradermal comparative test if false positive reaction or interference reaction is suspected.

2.2.5.3.2. <Substitution ChangeId="O001001M002" CommentaryRef="c000001"> <Substitution ChangeId="O008001M001" CommentaryRef="c000021">Intradermal comparative test for the establishment and maintenance of officially tuberculosis-free herd status:</Substitution> </Substitution>

positive: a positive bovine reaction which is more than 4 mm greater than the avian reaction, or the presence of clinical signs; inconclusive: a positive or inconclusive bovine reaction which is from 1 to 4 mm greater than the avian reaction, and the absence of clinical signs; negative: a negative bovine reaction, or a positive or inconclusive bovine reaction but which is equal to or less than a positive or inconclusive avian reaction and the absence of clinical signs in both cases.

Animals inconclusive to the intradermal comparative test shall be subjected to another test after a minimum of 42 days. Animals, which are not negative to this second test, shall be deemed to be positive to the test.

2.2.5.3.3. <Substitution ChangeId="O001001M002" CommentaryRef="c000001"> <Substitution ChangeId="O008001M001" CommentaryRef="c000021">Officially tuberculosis-free herd status may be suspended and animals from the herd shall not be allowed to enter intra-Community trade until such time as the status of the following animals is resolved:</Substitution> </Substitution>

animals which have been deemed to be inconclusive to the single intradermal tuberculin test; animals which have been deemed to be positive to the single intradermal tuberculin test but are awaiting retest with an intradermal comparative test; animals which have been deemed to be inconclusive to the intradermal comparative test.

2.2.5.3.4.

Where animals are required by Community legislation to be subjected to an intradermal test prior to movement, the test shall be interpreted so that no animal which shows an increase in skin-fold thickness greater than 2 mm or the presence of clinical signs is entered into intra-Community trade.

2.2.5.3.5.

To enable detection of the maximum number of infected and diseased animals in a herd or in a region, Member States may modify the criteria for the interpretation of the test in order to achieve improved test sensitivity considering all inconclusive reactions referred in 2.2.5.3.1(b) and 2.2.5.3.2(b) as positive reactions.

Substituted by Council Directive 97/12/EC of 17 March 1997 amending and updating Directive 64/432/EEC on health problems affecting intra-Community trade in bovine animals and swine. Substituted by Commission Regulation (EC) No 1226/2002 of 8 July 2002 amending Annex B to Council Directive 64/432/EEC.
This XML file does not appear to have any style information associated with it. The document tree is shown below.
<Legislation xmlns="http://www.legislation.gov.uk/namespaces/legislation" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" DocumentURI="http://www.legislation.gov.uk/eudr/1964/432" IdURI="http://www.legislation.gov.uk/id/eudr/1964/432" NumberOfProvisions="22" xsi:schemaLocation="http://www.legislation.gov.uk/namespaces/legislation http://www.legislation.gov.uk/schema/legislation.xsd" SchemaVersion="2.0" RestrictStartDate="2015-05-27" RestrictExtent="E+W+S+N.I.">
<ukm:Metadata xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dct="http://purl.org/dc/terms/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:ukm="http://www.legislation.gov.uk/namespaces/metadata">
<dc:identifier>http://www.legislation.gov.uk/eudr/1964/432/annex/B/division/2</dc:identifier>
<dc:title>Council Directive of 26 June 1964 on animal health problems affecting intra-Community trade in bovine animals and swine (64/432/EEC)</dc:title>
<dc:description>Council Directive of 26 June 1964 on animal health problems affecting intra-Community trade in bovine animals and swine (64/432/EEC)</dc:description>
<dc:modified>2020-12-12</dc:modified>
<dc:publisher>King's Printer of Acts of Parliament</dc:publisher>
<dc:source>https://webarchive.nationalarchives.gov.uk/eu-exit/https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:01964L0432-20150527</dc:source>
<dc:type>text</dc:type>
<dc:format>text/xml</dc:format>
<dc:language>en</dc:language>
<dct:valid>2015-05-27</dct:valid>
<atom:link rel="self" href="http://www.legislation.gov.uk/eudr/1964/432/annex/B/division/2/data.xml" type="application/xml"/>
<atom:link rel="http://www.legislation.gov.uk/def/navigation/resources" href="http://www.legislation.gov.uk/eudr/1964/432/resources" title="More Resources"/>
<atom:link rel="http://www.legislation.gov.uk/def/navigation/act" href="http://www.legislation.gov.uk/eudr/1964/432" title="whole act"/>
<atom:link rel="http://www.legislation.gov.uk/def/navigation/introduction" href="http://www.legislation.gov.uk/eudr/1964/432/introduction" title="introduction"/>
<atom:link rel="http://www.legislation.gov.uk/def/navigation/body" href="http://www.legislation.gov.uk/eudr/1964/432/body" title="body"/>
<atom:link rel="http://www.legislation.gov.uk/def/navigation/annexes" href="http://www.legislation.gov.uk/eudr/1964/432/annexes" title="annexes"/>
<atom:link rel="http://www.legislation.gov.uk/def/date/euexitday" href="http://www.legislation.gov.uk/eudr/1964/432/annex/B/division/2/2020-01-31" title="2020-01-31"/>
<atom:link rel="http://www.legislation.gov.uk/def/date/euexitTransitionEnd" href="http://www.legislation.gov.uk/eudr/1964/432/annex/B/division/2/2020-12-31" title="2020-12-31"/>
<atom:link rel="alternate" type="application/rdf+xml" href="http://www.legislation.gov.uk/eudr/1964/432/annex/B/division/2/data.rdf" title="RDF/XML"/>
<atom:link rel="alternate" type="application/akn+xml" href="http://www.legislation.gov.uk/eudr/1964/432/annex/B/division/2/data.akn" title="AKN"/>
<atom:link rel="alternate" type="application/xhtml+xml" href="http://www.legislation.gov.uk/eudr/1964/432/annex/B/division/2/data.xht" title="HTML snippet"/>
<atom:link rel="alternate" type="text/html" href="http://www.legislation.gov.uk/eudr/1964/432/annex/B/division/2/data.htm" title="Website (XHTML) Default View"/>
<atom:link rel="alternate" type="text/csv" href="http://www.legislation.gov.uk/eudr/1964/432/annex/B/division/2/data.csv" title="CSV"/>
<atom:link rel="alternate" type="application/pdf" href="http://www.legislation.gov.uk/eudr/1964/432/annex/B/division/2/data.pdf" title="PDF"/>
<atom:link rel="alternate" type="application/akn+xhtml" href="http://www.legislation.gov.uk/eudr/1964/432/annex/B/division/2/data.html" title="HTML5 snippet"/>
<atom:link rel="http://purl.org/dc/terms/tableOfContents" hreflang="en" href="http://www.legislation.gov.uk/eudr/1964/432/contents" title="Table of Contents"/>
<atom:link rel="http://purl.org/dc/terms/replaces" href="http://www.legislation.gov.uk/eudr/1964/432/annex/B/division/2/2005-07-09" title="2005-07-09"/>
<atom:link rel="http://purl.org/dc/terms/hasVersion" href="http://www.legislation.gov.uk/eudr/1964/432/annex/B/division/2/2005-07-09" title="2005-07-09"/>
<atom:link rel="http://purl.org/dc/terms/hasVersion" href="http://www.legislation.gov.uk/eudr/1964/432/annex/B/division/2/2007-01-05" title="2007-01-05"/>
<atom:link rel="up" href="http://www.legislation.gov.uk/eudr/1964/432/annex/B" title="Annex B"/>
<atom:link rel="prev" href="http://www.legislation.gov.uk/eudr/1964/432/annex/B/division/1" title="Division; Annex B Division 1"/>
<atom:link rel="prevInForce" href="http://www.legislation.gov.uk/eudr/1964/432/annex/B/division/1" title="Division; Annex B Division 1"/>
<atom:link rel="next" href="http://www.legislation.gov.uk/eudr/1964/432/annex/B/division/3" title="Division; Annex B Division 3"/>
<atom:link rel="nextInForce" href="http://www.legislation.gov.uk/eudr/1964/432/annex/B/division/3" title="Division; Annex B Division 3"/>
<ukm:EUMetadata>
<ukm:DocumentClassification>
<ukm:DocumentCategory Value="euretained"/>
<ukm:DocumentMainType Value="EuropeanUnionDirective"/>
<ukm:DocumentStatus Value="revised"/>
</ukm:DocumentClassification>
<ukm:Year Value="1964"/>
<ukm:Number Value="432"/>
<ukm:EURLexIdentifiers>
<ukm:Cellar Value="3aa37750-a7df-4f38-99ed-b67fad0e31ba"/>
<ukm:CELEX Value="01964L0432-20150527"/>
<ukm:ELI Value="dir:1964:432:2015-05-27"/>
</ukm:EURLexIdentifiers>
<ukm:EnactmentDate Date="1964-06-26"/>
<ukm:EURLexModified Date="2020-03-25T13:20:13Z"/>
<ukm:EURLexExtracted Date="2020-03-25T20:42:08Z"/>
<ukm:XMLGenerated Date="2020-12-12T14:42:53Z"/>
<ukm:XMLImported Date="2020-12-12T20:35:03Z"/>
<ukm:CreatedBy Label="Provisional data" URI="http://publications.europa.eu/resource/authority/corporate-body/OP_DATPRO"/>
<ukm:EURLexMetadata>
<WORK xmlns="">
<URI>
<VALUE>http://publications.europa.eu/resource/cellar/3aa37750-a7df-4f38-99ed-b67fad0e31ba</VALUE>
<IDENTIFIER>3aa37750-a7df-4f38-99ed-b67fad0e31ba</IDENTIFIER>
<TYPE>cellar</TYPE>
</URI>
<SAMEAS>
<URI>
<VALUE>http://publications.europa.eu/resource/celex/01964L0432-20150527</VALUE>
<IDENTIFIER>01964L0432-20150527</IDENTIFIER>
<TYPE>celex</TYPE>
</URI>
</SAMEAS>
<SAMEAS>
<URI>
<VALUE>http://publications.europa.eu/resource/consolidation/1964L0432%2F20150527</VALUE>
<IDENTIFIER>1964L0432/20150527</IDENTIFIER>
<TYPE>consolidation</TYPE>
</URI>
</SAMEAS>
<SAMEAS>
<URI>
<VALUE>http://publications.europa.eu/resource/eli/dir/1964/432/2015-05-27</VALUE>
<IDENTIFIER>dir:1964:432:2015-05-27</IDENTIFIER>
<TYPE>eli</TYPE>
</URI>
</SAMEAS>
<IDENTIFIER type="data">
<VALUE>01964L0432-20150527</VALUE>
</IDENTIFIER>
<ID_CELEX type="data">
<VALUE>01964L0432-20150527</VALUE>
</ID_CELEX>
<ACT_CONSOLIDATED_CONSOLIDATES_RESOURCE_LEGAL type="link">
<URI>
<VALUE>http://publications.europa.eu/resource/cellar/bde61520-12d4-11e9-81b4-01aa75ed71a1</VALUE>
<IDENTIFIER>bde61520-12d4-11e9-81b4-01aa75ed71a1</IDENTIFIER>
<TYPE>cellar</TYPE>
</URI>
<SAMEAS>
<URI>
<VALUE>http://publications.europa.eu/resource/oj/JOL_2019_005_R_0007</VALUE>
<IDENTIFIER>JOL_2019_005_R_0007</IDENTIFIER>
<TYPE>oj</TYPE>
</URI>
</SAMEAS>
<SAMEAS>
<URI>
<VALUE>http://publications.europa.eu/resource/celex/32015D0819R%2801%29</VALUE>
<IDENTIFIER>32015D0819R(01)</IDENTIFIER>
<TYPE>celex</TYPE>
</URI>
</SAMEAS>
<SAMEAS>
<URI>
<VALUE>http://publications.europa.eu/resource/eli/dec_impl/2015/819/corrigendum/2019-01-08/oj</VALUE>
<IDENTIFIER>dec_impl:2015:819:corrigendum:2019-01-08:oj</IDENTIFIER>
<TYPE>eli</TYPE>
</URI>
</SAMEAS>
</ACT_CONSOLIDATED_CONSOLIDATES_RESOURCE_LEGAL>
<LASTMODIFICATIONDATE type="date">
<VALUE>2020-03-25T14:20:13.379+01:00</VALUE>
<YEAR>2020</YEAR>
<MONTH>03</MONTH>
<DAY>25</DAY>
</LASTMODIFICATIONDATE>
<DATE_DOCUMENT type="date">
<VALUE>2015-05-27</VALUE>
<YEAR>2015</YEAR>
<MONTH>05</MONTH>
<DAY>27</DAY>
</DATE_DOCUMENT>
<IDENTIFIER type="data">
<VALUE>consolidation:1964L0432/20150527</VALUE>
</IDENTIFIER>
<RESOURCE_LEGAL_NUMBER_NATURAL_CELEX type="data">
<VALUE>0432</VALUE>
</RESOURCE_LEGAL_NUMBER_NATURAL_CELEX>
<RESOURCE_LEGAL_ELI type="data">
<VALUE>http://data.europa.eu/eli/dir/1964/432/2015-05-27</VALUE>
</RESOURCE_LEGAL_ELI>
<RESOURCE_LEGAL_NUMBER_NATURAL type="data">
<VALUE>432</VALUE>
</RESOURCE_LEGAL_NUMBER_NATURAL>
<CREATIONDATE type="date">
<VALUE>1001-01-01T00:00:00.000+00:00</VALUE>
<YEAR>1001</YEAR>
<MONTH>01</MONTH>
<DAY>01</DAY>
</CREATIONDATE>
<WORK_ID_DOCUMENT type="data">
<VALUE>celex:01964L0432-20150527</VALUE>
</WORK_ID_DOCUMENT>
<ELI type="data">
<VALUE>http://data.europa.eu/eli/dir/1964/432/2015-05-27</VALUE>
</ELI>
<RESOURCE_LEGAL_YEAR type="data">
<VALUE>1964</VALUE>
</RESOURCE_LEGAL_YEAR>
<YEAR type="data">
<VALUE>1964</VALUE>
</YEAR>
<IDENTIFIER type="data">
<VALUE>http://data.europa.eu/eli/dir/1964/432/2015-05-27</VALUE>
</IDENTIFIER>
<IDENTIFIER type="data">
<VALUE>celex:01964L0432-20150527</VALUE>
</IDENTIFIER>
<DATE_CREATION_LEGACY type="date">
<VALUE>2015-07-02</VALUE>
<YEAR>2015</YEAR>
<MONTH>07</MONTH>
<DAY>02</DAY>
</DATE_CREATION_LEGACY>
<VERSION type="data">
<VALUE>final</VALUE>
</VERSION>
<DATE type="date">
<VALUE>2015-07-02</VALUE>
<YEAR>2015</YEAR>
<MONTH>07</MONTH>
<DAY>02</DAY>
</DATE>
<RESOURCE_LEGAL_INFORMATION_MISCELLANEOUS type="data">
<VALUE>LASTMODIN {32015D0819R(01)|http://publications.europa.eu/resource/celex/32015D0819R(01)}</VALUE>
</RESOURCE_LEGAL_INFORMATION_MISCELLANEOUS>
<WORK_CREATED_BY_AGENT type="concept">
<URI>
<VALUE>http://publications.europa.eu/resource/authority/corporate-body/OP_DATPRO</VALUE>
<IDENTIFIER>OP_DATPRO</IDENTIFIER>
<TYPE>corporate-body</TYPE>
</URI>
<OP-CODE>OP_DATPRO</OP-CODE>
<IDENTIFIER>OP_DATPRO</IDENTIFIER>
<PREFLABEL>Provisional data</PREFLABEL>
</WORK_CREATED_BY_AGENT>
<RESOURCE_LEGAL_TYPE type="data">
<VALUE>L</VALUE>
</RESOURCE_LEGAL_TYPE>
<RESOURCE_LEGAL_DATE_ENTRY-INTO-FORCE type="date">
<VALUE>2015-05-27</VALUE>
<YEAR>2015</YEAR>
<MONTH>05</MONTH>
<DAY>27</DAY>
</RESOURCE_LEGAL_DATE_ENTRY-INTO-FORCE>
<ACT_CONSOLIDATED_CONSOLIDATES_RESOURCE_LEGAL type="link">
<URI>
<VALUE>http://publications.europa.eu/resource/cellar/9e82d969-345b-4878-92b8-56335bd49985</VALUE>
<IDENTIFIER>9e82d969-345b-4878-92b8-56335bd49985</IDENTIFIER>
<TYPE>cellar</TYPE>
</URI>
<SAMEAS>
<URI>
<VALUE>http://publications.europa.eu/resource/eli/dir/1964/432/2008-09-03</VALUE>
<IDENTIFIER>dir:1964:432:2008-09-03</IDENTIFIER>
<TYPE>eli</TYPE>
</URI>
</SAMEAS>
<SAMEAS>
<URI>
<VALUE>http://publications.europa.eu/resource/consolidation/1964L0432%2F20080903</VALUE>
<IDENTIFIER>1964L0432/20080903</IDENTIFIER>
<TYPE>consolidation</TYPE>
</URI>
</SAMEAS>
<SAMEAS>
<URI>
<VALUE>http://publications.europa.eu/resource/celex/01964L0432-20080903</VALUE>
<IDENTIFIER>01964L0432-20080903</IDENTIFIER>
<TYPE>celex</TYPE>
</URI>
</SAMEAS>
</ACT_CONSOLIDATED_CONSOLIDATES_RESOURCE_LEGAL>
<CREATED_BY type="concept">
<URI>
<VALUE>http://publications.europa.eu/resource/authority/corporate-body/OP_DATPRO</VALUE>
<IDENTIFIER>OP_DATPRO</IDENTIFIER>
<TYPE>corporate-body</TYPE>
</URI>
<OP-CODE>OP_DATPRO</OP-CODE>
<IDENTIFIER>OP_DATPRO</IDENTIFIER>
<PREFLABEL>Provisional data</PREFLABEL>
</CREATED_BY>
<ACT_CONSOLIDATED_DATE type="date">
<VALUE>2015-05-27</VALUE>
<YEAR>2015</YEAR>
<MONTH>05</MONTH>
<DAY>27</DAY>
</ACT_CONSOLIDATED_DATE>
<ACT_CONSOLIDATED_BASED_ON_RESOURCE_LEGAL type="link">
<URI>
<VALUE>http://publications.europa.eu/resource/cellar/b4b312f4-ba77-4cc7-99cd-5fc19c85d2cd</VALUE>
<IDENTIFIER>b4b312f4-ba77-4cc7-99cd-5fc19c85d2cd</IDENTIFIER>
<TYPE>cellar</TYPE>
</URI>
<SAMEAS>
<URI>
<VALUE>http://publications.europa.eu/resource/eli/dir/1964/432/oj</VALUE>
<IDENTIFIER>dir:1964:432:oj</IDENTIFIER>
<TYPE>eli</TYPE>
</URI>
</SAMEAS>
<SAMEAS>
<URI>
<VALUE>http://publications.europa.eu/resource/oj/JOP_1964_121_1977_004</VALUE>
<IDENTIFIER>JOP_1964_121_1977_004</IDENTIFIER>
<TYPE>oj</TYPE>
</URI>
</SAMEAS>
<SAMEAS>
<URI>
<VALUE>http://publications.europa.eu/resource/celex/31964L0432</VALUE>
<IDENTIFIER>31964L0432</IDENTIFIER>
<TYPE>celex</TYPE>
</URI>
</SAMEAS>
</ACT_CONSOLIDATED_BASED_ON_RESOURCE_LEGAL>
<ACT_CONSOLIDATED_CONSOLIDATES_RESOURCE_LEGAL type="link">
<URI>
<VALUE>http://publications.europa.eu/resource/cellar/b4b312f4-ba77-4cc7-99cd-5fc19c85d2cd</VALUE>
<IDENTIFIER>b4b312f4-ba77-4cc7-99cd-5fc19c85d2cd</IDENTIFIER>
<TYPE>cellar</TYPE>
</URI>
<SAMEAS>
<URI>
<VALUE>http://publications.europa.eu/resource/eli/dir/1964/432/oj</VALUE>
<IDENTIFIER>dir:1964:432:oj</IDENTIFIER>
<TYPE>eli</TYPE>
</URI>
</SAMEAS>
<SAMEAS>
<URI>
<VALUE>http://publications.europa.eu/resource/oj/JOP_1964_121_1977_004</VALUE>
<IDENTIFIER>JOP_1964_121_1977_004</IDENTIFIER>
<TYPE>oj</TYPE>
</URI>
</SAMEAS>
<SAMEAS>
<URI>
<VALUE>http://publications.europa.eu/resource/celex/31964L0432</VALUE>
<IDENTIFIER>31964L0432</IDENTIFIER>
<TYPE>celex</TYPE>
</URI>
</SAMEAS>
</ACT_CONSOLIDATED_CONSOLIDATES_RESOURCE_LEGAL>
<DATE type="date">
<VALUE>2015-05-27</VALUE>
<YEAR>2015</YEAR>
<MONTH>05</MONTH>
<DAY>27</DAY>
</DATE>
<WORK_HAS_RESOURCE-TYPE type="concept">
<URI>
<VALUE>http://publications.europa.eu/resource/authority/resource-type/CONS_TEXT</VALUE>
<IDENTIFIER>CONS_TEXT</IDENTIFIER>
<TYPE>resource-type</TYPE>
</URI>
<OP-CODE>CONS_TEXT</OP-CODE>
<IDENTIFIER>CONS_TEXT</IDENTIFIER>
<PREFLABEL>Consolidated text</PREFLABEL>
</WORK_HAS_RESOURCE-TYPE>
<WORK_SUMMARIZED_BY_SUMMARY type="link">
<URI>
<VALUE>http://publications.europa.eu/resource/cellar/f1ff7364-5704-4206-bd7a-d07a10ff3af8</VALUE>
<IDENTIFIER>f1ff7364-5704-4206-bd7a-d07a10ff3af8</IDENTIFIER>
<TYPE>cellar</TYPE>
</URI>
<SAMEAS>
<URI>
<VALUE>http://publications.europa.eu/resource/uriserv/l12004</VALUE>
<IDENTIFIER>l12004</IDENTIFIER>
<TYPE>uriserv</TYPE>
</URI>
</SAMEAS>
<SAMEAS>
<URI>
<VALUE>http://publications.europa.eu/resource/legissum/l12004</VALUE>
<IDENTIFIER>l12004</IDENTIFIER>
<TYPE>legissum</TYPE>
</URI>
</SAMEAS>
</WORK_SUMMARIZED_BY_SUMMARY>
<BASED_ON type="link">
<URI>
<VALUE>http://publications.europa.eu/resource/cellar/b4b312f4-ba77-4cc7-99cd-5fc19c85d2cd</VALUE>
<IDENTIFIER>b4b312f4-ba77-4cc7-99cd-5fc19c85d2cd</IDENTIFIER>
<TYPE>cellar</TYPE>
</URI>
<SAMEAS>
<URI>
<VALUE>http://publications.europa.eu/resource/eli/dir/1964/432/oj</VALUE>
<IDENTIFIER>dir:1964:432:oj</IDENTIFIER>
<TYPE>eli</TYPE>
</URI>
</SAMEAS>
<SAMEAS>
<URI>
<VALUE>http://publications.europa.eu/resource/oj/JOP_1964_121_1977_004</VALUE>
<IDENTIFIER>JOP_1964_121_1977_004</IDENTIFIER>
<TYPE>oj</TYPE>
</URI>
</SAMEAS>
<SAMEAS>
<URI>
<VALUE>http://publications.europa.eu/resource/celex/31964L0432</VALUE>
<IDENTIFIER>31964L0432</IDENTIFIER>
<TYPE>celex</TYPE>
</URI>
</SAMEAS>
</BASED_ON>
<WORK_DATE_DOCUMENT type="date">
<VALUE>2015-05-27</VALUE>
<YEAR>2015</YEAR>
<MONTH>05</MONTH>
<DAY>27</DAY>
</WORK_DATE_DOCUMENT>
<WORK_ID_DOCUMENT type="data">
<VALUE>consolidation:1964L0432/20150527</VALUE>
</WORK_ID_DOCUMENT>
<ACT_CONSOLIDATED_CONSOLIDATES_RESOURCE_LEGAL type="link">
<URI>
<VALUE>http://publications.europa.eu/resource/cellar/a0df470a-c245-11e9-9d01-01aa75ed71a1</VALUE>
<IDENTIFIER>a0df470a-c245-11e9-9d01-01aa75ed71a1</IDENTIFIER>
<TYPE>cellar</TYPE>
</URI>
<SAMEAS>
<URI>
<VALUE>http://publications.europa.eu/resource/eli/dir/1997/12/corrigendum/2019-08-19/oj</VALUE>
<IDENTIFIER>dir:1997:12:corrigendum:2019-08-19:oj</IDENTIFIER>
<TYPE>eli</TYPE>
</URI>
</SAMEAS>
<SAMEAS>
<URI>
<VALUE>http://publications.europa.eu/resource/oj/JOL_2019_215_R_0007</VALUE>
<IDENTIFIER>JOL_2019_215_R_0007</IDENTIFIER>
<TYPE>oj</TYPE>
</URI>
</SAMEAS>
<SAMEAS>
<URI>
<VALUE>http://publications.europa.eu/resource/celex/31997L0012R%2804%29</VALUE>
<IDENTIFIER>31997L0012R(04)</IDENTIFIER>
<TYPE>celex</TYPE>
</URI>
</SAMEAS>
</ACT_CONSOLIDATED_CONSOLIDATES_RESOURCE_LEGAL>
<ID_SECTOR type="data">
<VALUE>0</VALUE>
</ID_SECTOR>
<RESOURCE_LEGAL_ID_CELEX type="data">
<VALUE>01964L0432-20150527</VALUE>
</RESOURCE_LEGAL_ID_CELEX>
<TYPE>cdm:act_consolidated</TYPE>
<TYPE>cdm:work</TYPE>
<TYPE>cdm:resource_legal</TYPE>
<TYPE>L</TYPE>
</WORK>
<EXPRESSION xmlns="">
<URI>
<VALUE>http://publications.europa.eu/resource/cellar/3aa37750-a7df-4f38-99ed-b67fad0e31ba.0020</VALUE>
<IDENTIFIER>3aa37750-a7df-4f38-99ed-b67fad0e31ba.0020</IDENTIFIER>
<TYPE>cellar</TYPE>
</URI>
<SAMEAS>
<URI>
<VALUE>http://publications.europa.eu/resource/celex/01964L0432-20150527.ENG</VALUE>
<IDENTIFIER>01964L0432-20150527.ENG</IDENTIFIER>
<TYPE>celex</TYPE>
</URI>
</SAMEAS>
<SAMEAS>
<URI>
<VALUE>http://publications.europa.eu/resource/consolidation/1964L0432%2F20150527.ENG</VALUE>
<IDENTIFIER>1964L0432/20150527.ENG</IDENTIFIER>
<TYPE>consolidation</TYPE>
</URI>
</SAMEAS>
<CREATIONDATE type="date">
<VALUE>1001-01-01T00:00:00.000+00:00</VALUE>
<YEAR>1001</YEAR>
<MONTH>01</MONTH>
<DAY>01</DAY>
</CREATIONDATE>
<TITLE type="data">
<VALUE>CELEX1</VALUE>
</TITLE>
<EXPRESSION_TITLE type="data">
<VALUE>Council Directive of 26 June 1964 on animal health problems affecting intra-Community trade in bovine animals and swine (64/432/EEC) </VALUE>
</EXPRESSION_TITLE>
<LANG type="data">
<VALUE>eng</VALUE>
</LANG>
<LASTMODIFICATIONDATE type="date">
<VALUE>2019-11-06T22:24:14.963+01:00</VALUE>
<YEAR>2019</YEAR>
<MONTH>11</MONTH>
<DAY>06</DAY>
</LASTMODIFICATIONDATE>
<EXPRESSION_USES_LANGUAGE type="concept">
<URI>
<VALUE>http://publications.europa.eu/resource/authority/language/ENG</VALUE>
<IDENTIFIER>ENG</IDENTIFIER>
<TYPE>language</TYPE>
</URI>
<OP-CODE>ENG</OP-CODE>
<IDENTIFIER>ENG</IDENTIFIER>
<PREFLABEL>English</PREFLABEL>
<ALTLABEL>English</ALTLABEL>
</EXPRESSION_USES_LANGUAGE>
<TITLE type="data">
<VALUE>Council Directive of 26 June 1964 on animal health problems affecting intra-Community trade in bovine animals and swine (64/432/EEC) </VALUE>
</TITLE>
<LANG type="data">
<VALUE>en</VALUE>
</LANG>
</EXPRESSION>
</ukm:EURLexMetadata>
<ukm:UnappliedEffects>
<ukm:UnappliedEffect Comments="date unknown" Type="partial suspension" AffectingProvisions="Decision" AffectedProvisions="Art. 4QUATER(1)(C)" AffectingURI="http://www.legislation.gov.uk/id/eudn/1985/35" RequiresApplied="false" AffectedNumber="432" AffectingYear="1985" Created="2020-12-12T20:38:52Z" URI="http://www.legislation.gov.uk/id/effect/upload-08eyzi44-18" Notes="This effect not applied to legislation.gov.uk. This effect was derived from EUR-Lex and is not a textual amendment" AffectedClass="EuropeanUnionDirective" EffectId="key-50bd32d5c7a4664427fcaab14a37e391" Modified="2020-12-12T20:38:52Z" AffectingNumber="35" AffectedYear="1964" AffectedURI="http://www.legislation.gov.uk/id/eudr/1964/432" Row="18" AffectingClass="EuropeanUnionDecision">
<ukm:AffectedTitle>Council Directive 64/432/EEC of 26 June 1964 on animal health problems affecting intra-Community trade in bovine animals and swine</ukm:AffectedTitle>
<ukm:AffectedProvisions>
<ukm:Section xmlns:err="http://www.legislation.gov.uk/namespaces/error" Ref="article-4QUATER-1-C" URI="http://www.legislation.gov.uk/id/eudr/1964/432/article/4QUATER/1/C" err:Ref="Section missing in legislation" Missing="true">Art. 4QUATER(1)(C)</ukm:Section>
</ukm:AffectedProvisions>
<ukm:AffectingTitle>85/35/EEC: Commission Decision of 10 December 1984 temporarily suspending the status of certain parts of the territory of the Federal Republic of Germany with regard to classical swine fever</ukm:AffectingTitle>
<ukm:AffectingProvisions>Decision</ukm:AffectingProvisions>
<ukm:InForceDates>
<ukm:InForce Prospective="true" Qualification="" Applied="false"/>
</ukm:InForceDates>
</ukm:UnappliedEffect>
<ukm:UnappliedEffect RequiresApplied="false" AffectingNumber="162" AffectedYear="1964" EffectId="key-749109b1d8c9f3d5aaefeb95fced85f8" AffectedClass="EuropeanUnionDirective" AffectingYear="1985" Modified="2020-12-12T20:38:52Z" Type="partial suspension" AffectingClass="EuropeanUnionDecision" URI="http://www.legislation.gov.uk/id/effect/upload-08eyzi44-24" AffectingURI="http://www.legislation.gov.uk/id/eudn/1985/162" Row="24" AffectedProvisions="Art. 4QUATER(1)(C)" AffectedURI="http://www.legislation.gov.uk/id/eudr/1964/432" Created="2020-12-12T20:38:52Z" AffectingProvisions="Decision" AffectedNumber="432" Notes="This effect not applied to legislation.gov.uk. This effect was derived from EUR-Lex and is not a textual amendment" Comments="date unknown">
<ukm:AffectedTitle>Council Directive 64/432/EEC of 26 June 1964 on animal health problems affecting intra-Community trade in bovine animals and swine</ukm:AffectedTitle>
<ukm:AffectedProvisions>
<ukm:Section xmlns:err="http://www.legislation.gov.uk/namespaces/error" Ref="article-4QUATER-1-C" URI="http://www.legislation.gov.uk/id/eudr/1964/432/article/4QUATER/1/C" err:Ref="Section missing in legislation" Missing="true">Art. 4QUATER(1)(C)</ukm:Section>
</ukm:AffectedProvisions>
<ukm:AffectingTitle>85/162/EEC: Commission Decision of 6 February 1985 temporarily suspending the status of certain parts of the territory of the Federal Republic of Germany with regard to classical swine fever</ukm:AffectingTitle>
<ukm:AffectingProvisions>Decision</ukm:AffectingProvisions>
<ukm:InForceDates>
<ukm:InForce Prospective="true" Qualification="" Applied="false"/>
</ukm:InForceDates>
</ukm:UnappliedEffect>
<ukm:UnappliedEffect AffectingNumber="429" AffectedYear="1964" AffectedNumber="432" Row="191" URI="http://www.legislation.gov.uk/id/effect/upload-08eyzi44-191" AffectingYear="2016" AffectedClass="EuropeanUnionDirective" AffectingClass="EuropeanUnionRegulation" AffectingProvisions="Regulation" Type="repeal" AffectedProvisions="Directive" AffectingURI="http://www.legislation.gov.uk/id/eur/2016/429" EffectId="key-ff7965e04f1704ac443dbb81a8387727" Created="2020-12-12T20:38:52Z" Notes="This amendment by the EU not applied to legislation.gov.uk because it is brought into force after IP completion day." RequiresApplied="false" Modified="2020-12-12T20:38:52Z" AffectedURI="http://www.legislation.gov.uk/id/eudr/1964/432">
<ukm:AffectedTitle>Council Directive 64/432/EEC of 26 June 1964 on animal health problems affecting intra-Community trade in bovine animals and swine</ukm:AffectedTitle>
<ukm:AffectedProvisions>Directive</ukm:AffectedProvisions>
<ukm:AffectingTitle>Regulation (EU) 2016/429 of the European Parliament and of the Council of 9 March 2016 on transmissible animal diseases and amending and repealing certain acts in the area of animal health (‘Animal Health Law’) (Text with EEA relevance)</ukm:AffectingTitle>
<ukm:AffectingProvisions>Regulation</ukm:AffectingProvisions>
<ukm:InForceDates>
<ukm:InForce Date="2021-04-21" Qualification="wholly in force" Applied="false"/>
</ukm:InForceDates>
</ukm:UnappliedEffect>
</ukm:UnappliedEffects>
</ukm:EUMetadata>
<ukm:Alternatives>
<ukm:Alternative URI="http://www.legislation.gov.uk/eudr/1964/432/pdfs/eudr_19640432_adopted_en.pdf" Date="1964-06-26" Size="1759437"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eudr/1964/432/pdfs/eudr_19640432_1964-06-30_en.pdf" Date="1964-06-30" Size="485597" Revised="1964-06-30"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eudr/1964/432/pdfs/eudr_19640432_1998-07-01_en.pdf" Date="1998-07-01" Size="266226" Revised="1998-07-01"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eudr/1964/432/pdfs/eudr_19640432_1998-07-15_en.pdf" Date="1998-07-15" Size="479308" Revised="1998-07-15"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eudr/1964/432/pdfs/eudr_19640432_1998-12-31_en.pdf" Date="1998-12-31" Size="483106" Revised="1998-12-31"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eudr/1964/432/pdfs/eudr_19640432_2000-05-03_en.pdf" Date="2000-05-03" Size="2995973" Revised="2000-05-03"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eudr/1964/432/pdfs/eudr_19640432_2000-07-04_en.pdf" Date="2000-07-04" Size="717741" Revised="2000-07-04"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eudr/1964/432/pdfs/eudr_19640432_2001-07-31_en.pdf" Date="2001-07-31" Size="633691" Revised="2001-07-31"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eudr/1964/432/pdfs/eudr_19640432_2002-04-12_en.pdf" Date="2002-04-12" Size="610042" Revised="2002-04-12"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eudr/1964/432/pdfs/eudr_19640432_2002-07-29_en.pdf" Date="2002-07-29" Size="613665" Revised="2002-07-29"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eudr/1964/432/pdfs/eudr_19640432_2004-05-01_en.pdf" Date="2004-05-01" Size="596614" Revised="2004-05-01"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eudr/1964/432/pdfs/eudr_19640432_2005-07-09_en.pdf" Date="2005-07-09" Size="609152" Revised="2005-07-09"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eudr/1964/432/pdfs/eudr_19640432_2007-01-05_en.pdf" Date="2007-01-05" Size="471363" Revised="2007-01-05"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eudr/1964/432/pdfs/eudr_19640432_2007-11-13_en.pdf" Date="2007-11-13" Size="469537" Revised="2007-11-13"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eudr/1964/432/pdfs/eudr_19640432_2008-09-03_en.pdf" Date="2008-09-03" Size="445822" Revised="2008-09-03"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eudr/1964/432/pdfs/eudr_19640432_2008-12-31_en.pdf" Date="2008-12-31" Size="448905" Revised="2008-12-31"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eudr/1964/432/pdfs/eudr_19640432_2009-12-18_en.pdf" Date="2009-12-18" Size="1258357" Revised="2009-12-18"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eudr/1964/432/pdfs/eudr_19640432_2013-07-01_en.pdf" Date="2013-07-01" Size="1259185" Revised="2013-07-01"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eudr/1964/432/pdfs/eudr_19640432_2014-07-17_en.pdf" Date="2014-07-17" Size="1263501" Revised="2014-07-17"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eudr/1964/432/pdfs/eudr_19640432_2015-01-01_en.pdf" Date="2015-01-01" Size="1129008" Revised="2015-01-01"/>
<ukm:Alternative URI="http://www.legislation.gov.uk/eudr/1964/432/pdfs/eudr_19640432_2015-05-27_en.pdf" Date="2015-05-27" Size="1089359" Revised="2015-05-27"/>
</ukm:Alternatives>
<ukm:CorrectionSlips>
<ukm:CorrectionSlip URI="http://www.legislation.gov.uk/eudr/1964/432/pdfs/eudrcs_19640432_en_001.pdf" Date="1975-05-13" Size="78484"/>
</ukm:CorrectionSlips>
<ukm:Statistics>
<ukm:TotalParagraphs Value="209"/>
<ukm:BodyParagraphs Value="22"/>
<ukm:ScheduleParagraphs Value="187"/>
<ukm:AttachmentParagraphs Value="0"/>
<ukm:TotalImages Value="16"/>
</ukm:Statistics>
</ukm:Metadata>
<EURetained>
<Schedules RestrictStartDate="2015-05-27" RestrictExtent="E+W+S+N.I.">
<Schedule DocumentURI="http://www.legislation.gov.uk/eudr/1964/432/annex/B" IdURI="http://www.legislation.gov.uk/id/eudr/1964/432/annex/B" id="annex-B" RestrictStartDate="2008-09-03" RestrictExtent="E+W+S+N.I.">
<Number>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">ANNEX B</Substitution>
</Substitution>
</Number>
<TitleBlock>
<Title>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">TUBERCULOSIS</Substitution>
</Substitution>
</Title>
</TitleBlock>
<ScheduleBody>
<Division DocumentURI="http://www.legislation.gov.uk/eudr/1964/432/annex/B/division/2" IdURI="http://www.legislation.gov.uk/id/eudr/1964/432/annex/B/division/2" id="annex-B-division-2" RestrictStartDate="2007-01-05" RestrictExtent="E+W+S+N.I.">
<Number>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">2.</Substitution>
</Substitution>
</Number>
<Title>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">THE TUBERCULIN SKIN TEST</Substitution>
</Substitution>
</Title>
<P>
<Text>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">Tuberculin PPD (Purified Protein Derivatives) that fulfil the standards laid down in paragraph 2.1 shall be used for carrying out official tuberculin skin test following the procedures referred to in paragraph 2.2.</Substitution>
</Substitution>
</Text>
</P>
<Division DocumentURI="http://www.legislation.gov.uk/eudr/1964/432/annex/B/division/2/division/2.1" IdURI="http://www.legislation.gov.uk/id/eudr/1964/432/annex/B/division/2/division/2.1" id="annex-B-division-2-division-2.1" RestrictStartDate="2007-01-05" RestrictExtent="E+W+S+N.I.">
<Number>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">2.1.</Substitution>
</Substitution>
</Number>
<Title>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">Standards for tuberculin (bovine and avian)</Substitution>
</Substitution>
</Title>
<Division DocumentURI="http://www.legislation.gov.uk/eudr/1964/432/annex/B/division/2/division/2.1/division/2.1.1" IdURI="http://www.legislation.gov.uk/id/eudr/1964/432/annex/B/division/2/division/2.1/division/2.1.1" id="annex-B-division-2-division-2.1-division-2.1.1" RestrictStartDate="2007-01-05" RestrictExtent="E+W+S+N.I.">
<Number>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">2.1.1.</Substitution>
</Substitution>
</Number>
<Title>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">Definition</Substitution>
</Substitution>
</Title>
<P>
<Text>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">Tuberculin purified protein derivative (tuberculin PPD, bovine or avian) is a preparation obtained from the heat-treated products of growth and lysis of </Substitution>
</Substitution>
<Emphasis>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">Mycobacterium bovis</Substitution>
</Substitution>
</Emphasis>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021"> or </Substitution>
</Substitution>
<Emphasis>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">Mycobacterium avium</Substitution>
</Substitution>
</Emphasis>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021"> (as appropiate) capable of revealing a delayed hypersensitivity in an animal sensitised to microorganisms of the same species.</Substitution>
</Substitution>
</Text>
</P>
</Division>
<Division DocumentURI="http://www.legislation.gov.uk/eudr/1964/432/annex/B/division/2/division/2.1/division/2.1.2" IdURI="http://www.legislation.gov.uk/id/eudr/1964/432/annex/B/division/2/division/2.1/division/2.1.2" id="annex-B-division-2-division-2.1-division-2.1.2" RestrictStartDate="2007-01-05" RestrictExtent="E+W+S+N.I.">
<Number>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">2.1.2.</Substitution>
</Substitution>
</Number>
<Title>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">Production</Substitution>
</Substitution>
</Title>
<P>
<Text>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">It is obtained from the water-soluble fractions prepared by heating in free-flowing steam and subsequently filtering cultures of </Substitution>
</Substitution>
<Emphasis>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">M. bovis</Substitution>
</Substitution>
</Emphasis>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021"> or </Substitution>
</Substitution>
<Emphasis>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">M. avium</Substitution>
</Substitution>
</Emphasis>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021"> (as appropiate) grown in a liquid synthetic medium. The active fraction of the filtrate, consisting mainly of protein, is isolated by precipitation, washed and re-dissolved. An antimicrobial preservative that does not give rise to false positive reactions, such as phenol, may be added. The final sterile preparation, free from mycobacteria, is distributed aseptically into sterile tamper-proof glass containers which are then closed so as to prevent contamination. The preparation may be freeze-dried.</Substitution>
</Substitution>
</Text>
</P>
</Division>
<Division DocumentURI="http://www.legislation.gov.uk/eudr/1964/432/annex/B/division/2/division/2.1/division/2.1.3" IdURI="http://www.legislation.gov.uk/id/eudr/1964/432/annex/B/division/2/division/2.1/division/2.1.3" id="annex-B-division-2-division-2.1-division-2.1.3" RestrictStartDate="2007-01-05" RestrictExtent="E+W+S+N.I.">
<Number>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">2.1.3.</Substitution>
</Substitution>
</Number>
<Title>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">Identification of the product</Substitution>
</Substitution>
</Title>
<P>
<Text>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">Inject a range of graded doses intradermally at different sites into suitably sensitised albino guinea-pigs, each weighing not less than 250 g. After 24 h to 28 h, reactions appear in the form of oedematous swellings with erythema with or without necrosis at the points of injection. The size and severity of the reactions vary according to the dose. Unsensitised guinea-pigs show no reactions to similar injections.</Substitution>
</Substitution>
</Text>
</P>
</Division>
<Division DocumentURI="http://www.legislation.gov.uk/eudr/1964/432/annex/B/division/2/division/2.1/division/2.1.4" IdURI="http://www.legislation.gov.uk/id/eudr/1964/432/annex/B/division/2/division/2.1/division/2.1.4" id="annex-B-division-2-division-2.1-division-2.1.4" RestrictStartDate="2007-01-05" RestrictExtent="E+W+S+N.I.">
<Number>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">2.1.4.</Substitution>
</Substitution>
</Number>
<Title>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">Tests</Substitution>
</Substitution>
</Title>
<Division DocumentURI="http://www.legislation.gov.uk/eudr/1964/432/annex/B/division/2/division/2.1/division/2.1.4/division/2.1.4.1" IdURI="http://www.legislation.gov.uk/id/eudr/1964/432/annex/B/division/2/division/2.1/division/2.1.4/division/2.1.4.1" id="annex-B-division-2-division-2.1-division-2.1.4-division-2.1.4.1" RestrictStartDate="2007-01-05" RestrictExtent="E+W+S+N.I.">
<Number>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">2.1.4.1.</Substitution>
</Substitution>
</Number>
<P>
<Text>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">pH: The pH is 6.5 to 7.5.</Substitution>
</Substitution>
</Text>
</P>
</Division>
<Division DocumentURI="http://www.legislation.gov.uk/eudr/1964/432/annex/B/division/2/division/2.1/division/2.1.4/division/2.1.4.2" IdURI="http://www.legislation.gov.uk/id/eudr/1964/432/annex/B/division/2/division/2.1/division/2.1.4/division/2.1.4.2" id="annex-B-division-2-division-2.1-division-2.1.4-division-2.1.4.2" RestrictStartDate="2007-01-05" RestrictExtent="E+W+S+N.I.">
<Number>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">2.1.4.2.</Substitution>
</Substitution>
</Number>
<P>
<Text>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">Phenol: If the preparation to be examined contains phenol, its concentration is not more than 5 g/l.</Substitution>
</Substitution>
</Text>
</P>
</Division>
<Division DocumentURI="http://www.legislation.gov.uk/eudr/1964/432/annex/B/division/2/division/2.1/division/2.1.4/division/2.1.4.3" IdURI="http://www.legislation.gov.uk/id/eudr/1964/432/annex/B/division/2/division/2.1/division/2.1.4/division/2.1.4.3" id="annex-B-division-2-division-2.1-division-2.1.4-division-2.1.4.3" RestrictStartDate="2007-01-05" RestrictExtent="E+W+S+N.I.">
<Number>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">2.1.4.3.</Substitution>
</Substitution>
</Number>
<P>
<Text>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">Sensitising effect: Use a group of three guinea-pigs that have not been treated with any material which will interfere with the test. On 3 occasions at intervals of five days inject intradermally into each guinea-pig a dose of the preparation to be examined equivalent to 500 IU in 0,1 ml. 15 to 21 days after the third injection inject the same dose (500 IU) intradermally into these animals and into a control group of three guinea-pigs of the same mass and which have not previously received injections of tuberculin. 24 to 28 hours after the last injections, the reactions of the two groups are not significantly different.</Substitution>
</Substitution>
</Text>
</P>
</Division>
<Division DocumentURI="http://www.legislation.gov.uk/eudr/1964/432/annex/B/division/2/division/2.1/division/2.1.4/division/2.1.4.4" IdURI="http://www.legislation.gov.uk/id/eudr/1964/432/annex/B/division/2/division/2.1/division/2.1.4/division/2.1.4.4" id="annex-B-division-2-division-2.1-division-2.1.4-division-2.1.4.4" RestrictStartDate="2007-01-05" RestrictExtent="E+W+S+N.I.">
<Number>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">2.1.4.4.</Substitution>
</Substitution>
</Number>
<P>
<Text>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">Toxicity: Use two guinea-pigs, each weighing not less than 250 g and which have not previously been treated with any material which will interfere with the test. Inject subcutaneously into each guinea-pig 0,5 ml of the preparation to be examined. Observe the animals for seven days. No abnormal effects occur during the observation period.</Substitution>
</Substitution>
</Text>
</P>
</Division>
<Division DocumentURI="http://www.legislation.gov.uk/eudr/1964/432/annex/B/division/2/division/2.1/division/2.1.4/division/2.1.4.5" IdURI="http://www.legislation.gov.uk/id/eudr/1964/432/annex/B/division/2/division/2.1/division/2.1.4/division/2.1.4.5" id="annex-B-division-2-division-2.1-division-2.1.4-division-2.1.4.5" RestrictStartDate="2007-01-05" RestrictExtent="E+W+S+N.I.">
<Number>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">2.1.4.5.</Substitution>
</Substitution>
</Number>
<P>
<Text>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">Sterility: It complies with the test for sterility prescribed in the monograph on Vaccines for veterinary use 4th Edition 2002 of the European Pharmacopoeia.</Substitution>
</Substitution>
</Text>
</P>
</Division>
</Division>
<Division DocumentURI="http://www.legislation.gov.uk/eudr/1964/432/annex/B/division/2/division/2.1/division/2.1.5" IdURI="http://www.legislation.gov.uk/id/eudr/1964/432/annex/B/division/2/division/2.1/division/2.1.5" id="annex-B-division-2-division-2.1-division-2.1.5" RestrictStartDate="2007-01-05" RestrictExtent="E+W+S+N.I.">
<Number>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">2.1.5.</Substitution>
</Substitution>
</Number>
<Title>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">Potency</Substitution>
</Substitution>
</Title>
<P>
<Text>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">The potency of tuberculin purified protein derivative (bovine and avian) is determined by comparing the reactions produced in sensitised guinea-pigs by the intradermal injection of a series of dilutions of the preparation to be examined with those produced by known concentrations of a reference preparation of tuberculin (bovine or avian, as appropiate) purified protein derivative calibrated in International Units.</Substitution>
</Substitution>
</Text>
</P>
<P>
<Text>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">To test the potency, sensitise not fewer than nine albino guinea-pigs, each weighing 400 g to 600 g, by the deep intramuscular injection of 0,0001 mg of wet mass of living </Substitution>
</Substitution>
<Emphasis>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">M. bovis</Substitution>
</Substitution>
</Emphasis>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021"> of strain AN5 suspended in 0.5 ml of a 9 g/l solution of sodium chloride R for bovine tuberculin, or a suitable dose of inactivated or live </Substitution>
</Substitution>
<Emphasis>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">M. avium</Substitution>
</Substitution>
</Emphasis>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021"> for avian tuberculin. Not less than four weeks after the sensitisation of the guinea-pigs, shave their flanks to provide space for not more than four injection sites on each side. Prepare dilutions of the preparation to be examined and of the reference preparation using isotonic phosphate-buffered saline (pH 6,5-7,5) containing 0,005 g/l of polysorbate 80 R. Use not fewer than three doses of the reference preparation and not fewer than three doses of the preparation to be examined. Choose the doses such that the lesions produced have a diameter of not less than 8 mm and not more than 25 mm. Allocate the dilutions randomly to the sites using a Latin square design. Inject each dose intradermally in a constant volume of 0,1 ml or 0,2 ml. Measure the diameters of the lesions after 24 to 28 hours and calculate the result of the test using the usual statistical methods and assuming that the diameters of the lesions are directly proportional to the logarithm of the concentration of the tuberculins.</Substitution>
</Substitution>
</Text>
</P>
<P>
<Text>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">The test is not valid unless the fiducial limits of error (P = 0,95) are not less than 50 % and not more then 200 % of the estimated potency. The estimated potency is not less than 66 % and not more than 150 % of the stated potency for bovine tuberculin. The estimated potency is not less than 75 % and not more than 133 % of the stated potency for avian tuberculin. The stated potency is not less than </Substitution>
</Substitution>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">20 000</Substitution>
</Substitution>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021"> IU/ml for both tuberculins (bovine and avian).</Substitution>
</Substitution>
</Text>
</P>
</Division>
<Division DocumentURI="http://www.legislation.gov.uk/eudr/1964/432/annex/B/division/2/division/2.1/division/2.1.6" IdURI="http://www.legislation.gov.uk/id/eudr/1964/432/annex/B/division/2/division/2.1/division/2.1.6" id="annex-B-division-2-division-2.1-division-2.1.6" RestrictStartDate="2007-01-05" RestrictExtent="E+W+S+N.I.">
<Number>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">2.1.6.</Substitution>
</Substitution>
</Number>
<Title>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">Storage</Substitution>
</Substitution>
</Title>
<P>
<Text>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">Store protected from light, at a temperature of 5 ± 3 </Substitution>
</Substitution>
<Superior>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">o</Substitution>
</Substitution>
</Superior>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">C.</Substitution>
</Substitution>
</Text>
</P>
</Division>
<Division DocumentURI="http://www.legislation.gov.uk/eudr/1964/432/annex/B/division/2/division/2.1/division/2.1.7" IdURI="http://www.legislation.gov.uk/id/eudr/1964/432/annex/B/division/2/division/2.1/division/2.1.7" id="annex-B-division-2-division-2.1-division-2.1.7" RestrictStartDate="2007-01-05" RestrictExtent="E+W+S+N.I.">
<Number>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">2.1.7.</Substitution>
</Substitution>
</Number>
<Title>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">Labelling</Substitution>
</Substitution>
</Title>
<P>
<Text>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">The label states:</Substitution>
</Substitution>
</Text>
</P>
<P>
<UnorderedList Decoration="dash">
<ListItem>
<Para>
<Text>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">the potency in International Units per millilitre,</Substitution>
</Substitution>
</Text>
</Para>
</ListItem>
<ListItem>
<Para>
<Text>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">the name and quantity of any added substance,</Substitution>
</Substitution>
</Text>
</Para>
</ListItem>
<ListItem>
<Para>
<Text>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">for freeze-dried preparations:</Substitution>
</Substitution>
</Text>
</Para>
<UnorderedList Decoration="dash">
<ListItem>
<Para>
<Text>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">-the name and volume of the reconstituting liquid to be added,</Substitution>
</Substitution>
</Text>
</Para>
</ListItem>
<ListItem>
<Para>
<Text>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">-that the product should be used immediately after reconstitution.</Substitution>
</Substitution>
</Text>
</Para>
</ListItem>
</UnorderedList>
</ListItem>
</UnorderedList>
</P>
</Division>
</Division>
<Division DocumentURI="http://www.legislation.gov.uk/eudr/1964/432/annex/B/division/2/division/2.2" IdURI="http://www.legislation.gov.uk/id/eudr/1964/432/annex/B/division/2/division/2.2" id="annex-B-division-2-division-2.2" RestrictStartDate="2007-01-05" RestrictExtent="E+W+S+N.I.">
<Number>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">2.2.</Substitution>
</Substitution>
</Number>
<Title>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">Test procedures</Substitution>
</Substitution>
</Title>
<Division DocumentURI="http://www.legislation.gov.uk/eudr/1964/432/annex/B/division/2/division/2.2/division/2.2.1" IdURI="http://www.legislation.gov.uk/id/eudr/1964/432/annex/B/division/2/division/2.2/division/2.2.1" id="annex-B-division-2-division-2.2-division-2.2.1" RestrictStartDate="2007-01-05" RestrictExtent="E+W+S+N.I.">
<Number>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">2.2.1.</Substitution>
</Substitution>
</Number>
<Title>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">The following shall be recognised as official intradermal tuberculin tests:</Substitution>
</Substitution>
</Title>
<P>
<UnorderedList Decoration="dash">
<ListItem>
<Para>
<Text>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">the single intradermal test: this test requires a single injection of bovine tuberculin,</Substitution>
</Substitution>
</Text>
</Para>
</ListItem>
<ListItem>
<Para>
<Text>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">the intradermal comparative test: this test requires one injection of bovine tuberculin and one injection of avian tuberculin given simultaneously.</Substitution>
</Substitution>
</Text>
</Para>
</ListItem>
</UnorderedList>
</P>
</Division>
<Division DocumentURI="http://www.legislation.gov.uk/eudr/1964/432/annex/B/division/2/division/2.2/division/2.2.2" IdURI="http://www.legislation.gov.uk/id/eudr/1964/432/annex/B/division/2/division/2.2/division/2.2.2" id="annex-B-division-2-division-2.2-division-2.2.2" RestrictStartDate="2007-01-05" RestrictExtent="E+W+S+N.I.">
<Number>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">2.2.2.</Substitution>
</Substitution>
</Number>
<Title>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">The dose of tuberculin injected shall be:</Substitution>
</Substitution>
</Title>
<P>
<UnorderedList Decoration="dash">
<ListItem>
<Para>
<Text>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">not less than </Substitution>
</Substitution>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">2 000</Substitution>
</Substitution>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021"> IU of bovine tuberculin,</Substitution>
</Substitution>
</Text>
</Para>
</ListItem>
<ListItem>
<Para>
<Text>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">not less than </Substitution>
</Substitution>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">2 000</Substitution>
</Substitution>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021"> IU of avian tuberculin.</Substitution>
</Substitution>
</Text>
</Para>
</ListItem>
</UnorderedList>
</P>
</Division>
<Division DocumentURI="http://www.legislation.gov.uk/eudr/1964/432/annex/B/division/2/division/2.2/division/2.2.3" IdURI="http://www.legislation.gov.uk/id/eudr/1964/432/annex/B/division/2/division/2.2/division/2.2.3" id="annex-B-division-2-division-2.2-division-2.2.3" RestrictStartDate="2007-01-05" RestrictExtent="E+W+S+N.I.">
<Number>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">2.2.3.</Substitution>
</Substitution>
</Number>
<P>
<Text>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">The volume of each injection dose shall not exceed 0,2 ml.</Substitution>
</Substitution>
</Text>
</P>
</Division>
<Division DocumentURI="http://www.legislation.gov.uk/eudr/1964/432/annex/B/division/2/division/2.2/division/2.2.4" IdURI="http://www.legislation.gov.uk/id/eudr/1964/432/annex/B/division/2/division/2.2/division/2.2.4" id="annex-B-division-2-division-2.2-division-2.2.4" RestrictStartDate="2007-01-05" RestrictExtent="E+W+S+N.I.">
<Number>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">2.2.4.</Substitution>
</Substitution>
</Number>
<P>
<Text>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">Tuberculin tests shall be carried out by injecting tuberculin(s) into the skin of the neck. The injection sites shall be situated at the border of the anterior and middle thirds of the neck. When both avian and bovine tuberculins are injected in the same animal, the site for injection of avian tuberculins shall be about 10 cm from the crest of the neck and the site for the injection of bovine tuberculin about 12,5 cm lower on a line roughly parallel with the line of the shoulder or on different sides of the neck; in young animals in which there is not room to separate the sites sufficiently on one side of the neck, one injection shall be made on each side of the neck at identical sites in the centre of the middle third of the neck.</Substitution>
</Substitution>
</Text>
</P>
</Division>
<Division DocumentURI="http://www.legislation.gov.uk/eudr/1964/432/annex/B/division/2/division/2.2/division/2.2.5" IdURI="http://www.legislation.gov.uk/id/eudr/1964/432/annex/B/division/2/division/2.2/division/2.2.5" id="annex-B-division-2-division-2.2-division-2.2.5" RestrictStartDate="2007-01-05" RestrictExtent="E+W+S+N.I.">
<Number>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">2.2.5.</Substitution>
</Substitution>
</Number>
<P>
<Text>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">The technique of tuberculin testing and interpretation of reactions shall be as follows:</Substitution>
</Substitution>
</Text>
</P>
</Division>
<Division DocumentURI="http://www.legislation.gov.uk/eudr/1964/432/annex/B/division/2/division/2.2/division/2.2.5.1" IdURI="http://www.legislation.gov.uk/id/eudr/1964/432/annex/B/division/2/division/2.2/division/2.2.5.1" id="annex-B-division-2-division-2.2-division-2.2.5.1" RestrictStartDate="2007-01-05" RestrictExtent="E+W+S+N.I.">
<Number>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">2.2.5.1.</Substitution>
</Substitution>
</Number>
<Title>
<Expanded>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">Technique:</Substitution>
</Substitution>
</Expanded>
</Title>
<P>
<Text>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">Injection sites shall be clipped and cleansed. A fold of skin within each clipped area shall be taken between the forefinger and thumb and measured with callipers and recorded. The dose of tuberculin shall then be injected by a method that ensures that the tuberculin is delivered intradermically. A short sterile needle, bevel edge outwards, with graduated syringe charged with tuberculin, inserted obliquely into the deeper layers of the skin may be used. A correct injection shall be confirmed by palpating a small pea-like swelling at each site of injection. The skin-fold thickness of each injection site shall be remeasured 72 hours (± 4 hours) after injection and recorded.</Substitution>
</Substitution>
</Text>
</P>
</Division>
<Division DocumentURI="http://www.legislation.gov.uk/eudr/1964/432/annex/B/division/2/division/2.2/division/2.2.5.2" IdURI="http://www.legislation.gov.uk/id/eudr/1964/432/annex/B/division/2/division/2.2/division/2.2.5.2" id="annex-B-division-2-division-2.2-division-2.2.5.2" RestrictStartDate="2007-01-05" RestrictExtent="E+W+S+N.I.">
<Number>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">2.2.5.2.</Substitution>
</Substitution>
</Number>
<Title>
<Expanded>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">Interpretation of reactions</Substitution>
</Substitution>
</Expanded>
</Title>
<P>
<Text>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">The interpretation of reactions shall be based on clinical observations and the recorded increase(s) in skin-fold thickness at the sites of injection 72 hours after injection of tuberculin(s).</Substitution>
</Substitution>
</Text>
</P>
<P>
<OrderedList Type="alpha" Decoration="parens">
<ListItem NumberOverride="(a)">
<Para>
<Text>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">Negative reaction: if only limited swelling is observed, with an increase of not more than 2 mm in the thickness of the fold of skin without clinical signs such as diffuse or extensive oedema, exudation, necrosis, pain or inflammation of the lymphatic ducts in that region or of the lymph nodes.</Substitution>
</Substitution>
</Text>
</Para>
</ListItem>
<ListItem NumberOverride="(b)">
<Para>
<Text>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">Inconclusive reaction: if no clinical signs such as mentioned in a) are observed and if the increase in skin-fold thickness is more than 2 mm and less than 4 mm.</Substitution>
</Substitution>
</Text>
</Para>
</ListItem>
<ListItem NumberOverride="(c)">
<Para>
<Text>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">Positive reaction: if clinical signs such as mentioned in a) are observed or there is an increase of 4 mm or more in the thickness of the fold of skin at the injection site.</Substitution>
</Substitution>
</Text>
</Para>
</ListItem>
</OrderedList>
</P>
</Division>
<Division DocumentURI="http://www.legislation.gov.uk/eudr/1964/432/annex/B/division/2/division/2.2/division/2.2.5.3" IdURI="http://www.legislation.gov.uk/id/eudr/1964/432/annex/B/division/2/division/2.2/division/2.2.5.3" id="annex-B-division-2-division-2.2-division-2.2.5.3" RestrictStartDate="2007-01-05" RestrictExtent="E+W+S+N.I.">
<Number>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">2.2.5.3.</Substitution>
</Substitution>
</Number>
<P>
<Text>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">The interpretation of official intradermal tuberculin tests shall be as follows:</Substitution>
</Substitution>
</Text>
</P>
</Division>
<Division DocumentURI="http://www.legislation.gov.uk/eudr/1964/432/annex/B/division/2/division/2.2/division/2.2.5.3.1" IdURI="http://www.legislation.gov.uk/id/eudr/1964/432/annex/B/division/2/division/2.2/division/2.2.5.3.1" id="annex-B-division-2-division-2.2-division-2.2.5.3.1" RestrictStartDate="2007-01-05" RestrictExtent="E+W+S+N.I.">
<Number>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">2.2.5.3.1.</Substitution>
</Substitution>
</Number>
<Title>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">Single intradermal test:</Substitution>
</Substitution>
</Title>
<P>
<OrderedList Type="alpha" Decoration="parens">
<ListItem NumberOverride="(a)">
<Para>
<Text>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">positive: a positive bovine reaction as defined in paragraph 2.2.5.2(c);</Substitution>
</Substitution>
</Text>
</Para>
</ListItem>
<ListItem NumberOverride="(b)">
<Para>
<Text>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">inconclusive: an inconclusive reaction as defined in paragraph 2.2.5.2(b);</Substitution>
</Substitution>
</Text>
</Para>
</ListItem>
<ListItem NumberOverride="(c)">
<Para>
<Text>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">negative: a negative bovine reaction as defined in paragraph 2.2.5.2(a).</Substitution>
</Substitution>
</Text>
</Para>
</ListItem>
</OrderedList>
</P>
<P>
<Text>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">Animals inconclusive to the single intradermal test shall be subjected to another test after a minimum of 42 days.</Substitution>
</Substitution>
</Text>
</P>
<P>
<Text>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">Animals which are not negative to this second test shall be deemed to be positive to the test.</Substitution>
</Substitution>
</Text>
</P>
<P>
<Text>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">Animals positive to the single intradermal test may be subjected to an intradermal comparative test if false positive reaction or interference reaction is suspected.</Substitution>
</Substitution>
</Text>
</P>
</Division>
<Division DocumentURI="http://www.legislation.gov.uk/eudr/1964/432/annex/B/division/2/division/2.2/division/2.2.5.3.2" IdURI="http://www.legislation.gov.uk/id/eudr/1964/432/annex/B/division/2/division/2.2/division/2.2.5.3.2" id="annex-B-division-2-division-2.2-division-2.2.5.3.2" RestrictStartDate="2007-01-05" RestrictExtent="E+W+S+N.I.">
<Number>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">2.2.5.3.2.</Substitution>
</Substitution>
</Number>
<Title>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">Intradermal comparative test for the establishment and maintenance of officially tuberculosis-free herd status:</Substitution>
</Substitution>
</Title>
<P>
<OrderedList Type="alpha" Decoration="parens">
<ListItem NumberOverride="(a)">
<Para>
<Text>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">positive: a positive bovine reaction which is more than 4 mm greater than the avian reaction, or the presence of clinical signs;</Substitution>
</Substitution>
</Text>
</Para>
</ListItem>
<ListItem NumberOverride="(b)">
<Para>
<Text>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">inconclusive: a positive or inconclusive bovine reaction which is from 1 to 4 mm greater than the avian reaction, and the absence of clinical signs;</Substitution>
</Substitution>
</Text>
</Para>
</ListItem>
<ListItem NumberOverride="(c)">
<Para>
<Text>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">negative: a negative bovine reaction, or a positive or inconclusive bovine reaction but which is equal to or less than a positive or inconclusive avian reaction and the absence of clinical signs in both cases.</Substitution>
</Substitution>
</Text>
</Para>
</ListItem>
</OrderedList>
</P>
<P>
<Text>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">Animals inconclusive to the intradermal comparative test shall be subjected to another test after a minimum of 42 days. Animals, which are not negative to this second test, shall be deemed to be positive to the test.</Substitution>
</Substitution>
</Text>
</P>
</Division>
<Division DocumentURI="http://www.legislation.gov.uk/eudr/1964/432/annex/B/division/2/division/2.2/division/2.2.5.3.3" IdURI="http://www.legislation.gov.uk/id/eudr/1964/432/annex/B/division/2/division/2.2/division/2.2.5.3.3" id="annex-B-division-2-division-2.2-division-2.2.5.3.3" RestrictStartDate="2007-01-05" RestrictExtent="E+W+S+N.I.">
<Number>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">2.2.5.3.3.</Substitution>
</Substitution>
</Number>
<Title>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">Officially tuberculosis-free herd status may be suspended and animals from the herd shall not be allowed to enter intra-Community trade until such time as the status of the following animals is resolved:</Substitution>
</Substitution>
</Title>
<P>
<OrderedList Type="alpha" Decoration="parens">
<ListItem NumberOverride="(a)">
<Para>
<Text>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">animals which have been deemed to be inconclusive to the single intradermal tuberculin test;</Substitution>
</Substitution>
</Text>
</Para>
</ListItem>
<ListItem NumberOverride="(b)">
<Para>
<Text>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">animals which have been deemed to be positive to the single intradermal tuberculin test but are awaiting retest with an intradermal comparative test;</Substitution>
</Substitution>
</Text>
</Para>
</ListItem>
<ListItem NumberOverride="(c)">
<Para>
<Text>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">animals which have been deemed to be inconclusive to the intradermal comparative test.</Substitution>
</Substitution>
</Text>
</Para>
</ListItem>
</OrderedList>
</P>
</Division>
<Division DocumentURI="http://www.legislation.gov.uk/eudr/1964/432/annex/B/division/2/division/2.2/division/2.2.5.3.4" IdURI="http://www.legislation.gov.uk/id/eudr/1964/432/annex/B/division/2/division/2.2/division/2.2.5.3.4" id="annex-B-division-2-division-2.2-division-2.2.5.3.4" RestrictStartDate="2007-01-05" RestrictExtent="E+W+S+N.I.">
<Number>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">2.2.5.3.4.</Substitution>
</Substitution>
</Number>
<P>
<Text>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">Where animals are required by Community legislation to be subjected to an intradermal test prior to movement, the test shall be interpreted so that no animal which shows an increase in skin-fold thickness greater than 2 mm or the presence of clinical signs is entered into intra-Community trade.</Substitution>
</Substitution>
</Text>
</P>
</Division>
<Division DocumentURI="http://www.legislation.gov.uk/eudr/1964/432/annex/B/division/2/division/2.2/division/2.2.5.3.5" IdURI="http://www.legislation.gov.uk/id/eudr/1964/432/annex/B/division/2/division/2.2/division/2.2.5.3.5" id="annex-B-division-2-division-2.2-division-2.2.5.3.5" RestrictStartDate="2007-01-05" RestrictExtent="E+W+S+N.I.">
<Number>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">2.2.5.3.5.</Substitution>
</Substitution>
</Number>
<P>
<Text>
<Substitution ChangeId="O001001M002" CommentaryRef="c000001">
<Substitution ChangeId="O008001M001" CommentaryRef="c000021">To enable detection of the maximum number of infected and diseased animals in a herd or in a region, Member States may modify the criteria for the interpretation of the test in order to achieve improved test sensitivity considering all inconclusive reactions referred in 2.2.5.3.1(b) and 2.2.5.3.2(b) as positive reactions.</Substitution>
</Substitution>
</Text>
</P>
</Division>
</Division>
</Division>
</ScheduleBody>
</Schedule>
</Schedules>
</EURetained>
<Commentaries>
<Commentary Type="F" Source="EU" id="c000001">
<Para>
<Text>
Substituted by
<Citation Class="EuropeanUnionDirective" Year="1997" Number="12" URI="http://www.legislation.gov.uk/id/eudr/1997/12" Title="Council Directive 97/12/EC of 17 March 1997 amending and updating Directive 64/432/EEC on health problems affecting intra-Community trade in bovine animals and swine">Council Directive 97/12/EC of 17 March 1997 amending and updating Directive 64/432/EEC on health problems affecting intra-Community trade in bovine animals and swine</Citation>
.
</Text>
</Para>
</Commentary>
<Commentary Type="F" Source="EU" id="c000021">
<Para>
<Text>
Substituted by
<Citation Class="EuropeanUnionRegulation" Year="2002" Number="1226" URI="http://www.legislation.gov.uk/id/eur/2002/1226" Title="Commission Regulation (EC) No 1226/2002 of 8 July 2002 amending Annex B to Council Directive 64/432/EEC">Commission Regulation (EC) No 1226/2002 of 8 July 2002 amending Annex B to Council Directive 64/432/EEC</Citation>
.
</Text>
</Para>
</Commentary>
</Commentaries>
</Legislation>